Literature DB >> 12833255

Structure and function of integral membrane protein domains resolved by peptide-amphiphiles: application to phospholamban.

Nathan A Lockwood1, Raymond S Tu, Zhiwen Zhang, Matthew V Tirrell, David D Thomas, Christine B Karim.   

Abstract

We have used synthetic lipidated peptides ("peptide-amphiphiles") to study the structure and function of isolated domains of integral transmembrane proteins. We used 9-fluorenylmethyloxycarbonyl (Fmoc) solid-phase peptide synthesis to prepare full-length phospholamban (PLB(1-52)) and its cytoplasmic (PLB(1-25)K: phospholamban residues 1-25 plus a C-terminal lysine), and transmembrane (PLB(26-52)) domains, and a 38-residue model alpha-helical sequence as a control. We created peptide-amphiphiles by linking the C-terminus of either the isolated cytoplasmic domain or the model peptide to a membrane-anchoring, lipid-like hydrocarbon tail. Circular dichroism measurements showed that the model peptide-amphiphile, either in aqueous suspension or in lipid bilayers, had a higher degree of alpha-helical secondary structure than the unlipidated model peptide. We hypothesized that the peptide-amphiphile system would allow us to study the function and structure of the PLB(1-25)K cytoplasmic domain in a native-like configuration. We compared the function (inhibition of the Ca-ATPase in reconstituted membranes) and structure (via CD) of the PLB(1-25) amphiphile to that of PLB and its isolated transmembrane and cytoplasmic domains. Our results indicate that the cytoplasmic domain PLB(1-25)K has no effect on Ca-ATPase (calcium pump) activity, even when tethered to the membrane in a manner mimicking its native configuration, and that the transmembrane domain of PLB is sufficient for inhibition of the Ca-ATPase. Copyright 2003 Wiley Periodicals, Inc. Biopolymers 69: 283-292, 2003

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12833255     DOI: 10.1002/bip.10365

Source DB:  PubMed          Journal:  Biopolymers        ISSN: 0006-3525            Impact factor:   2.505


  18 in total

1.  The alpha-helical propensity of the cytoplasmic domain of phospholamban: a molecular dynamics simulation of the effect of phosphorylation and mutation.

Authors:  M Germana Paterlini; David D Thomas
Journal:  Biophys J       Date:  2005-03-11       Impact factor: 4.033

2.  Rotational dynamics of HIV-1 nucleocapsid protein NCp7 as probed by a spin label attached by peptide synthesis.

Authors:  Zhiwen Zhang; Xiangmei Xi; Charles P Scholes; Christine B Karim
Journal:  Biopolymers       Date:  2008-12       Impact factor: 2.505

3.  Accurate quantitation of phospholamban phosphorylation by immunoblot.

Authors:  Naa-Adjeley Ablorh; Tyler Miller; Florentin Nitu; Simon J Gruber; Christine Karim; David D Thomas
Journal:  Anal Biochem       Date:  2012-02-03       Impact factor: 3.365

4.  Calcium-Dependent Structural Dynamics of a Spin-Labeled RyR Peptide Bound to Calmodulin.

Authors:  Cheng Her; Jesse E McCaffrey; David D Thomas; Christine B Karim
Journal:  Biophys J       Date:  2016-12-06       Impact factor: 4.033

5.  cAMP-dependent protein kinase A selects the excited state of the membrane substrate phospholamban.

Authors:  Larry R Masterson; Tao Yu; Lei Shi; Yi Wang; Martin Gustavsson; Michael M Mueller; Gianluigi Veglia
Journal:  J Mol Biol       Date:  2011-07-02       Impact factor: 5.469

6.  Lipid-mediated folding/unfolding of phospholamban as a regulatory mechanism for the sarcoplasmic reticulum Ca2+-ATPase.

Authors:  Martin Gustavsson; Nathaniel J Traaseth; Christine B Karim; Elizabeth L Lockamy; David D Thomas; Gianluigi Veglia
Journal:  J Mol Biol       Date:  2011-03-17       Impact factor: 5.469

7.  Phospholamban and its phosphorylated form interact differently with lipid bilayers: a 31P, 2H, and 13C solid-state NMR spectroscopic study.

Authors:  Shadi Abu-Baker; Gary A Lorigan
Journal:  Biochemistry       Date:  2006-11-07       Impact factor: 3.162

8.  Phospholamban structural dynamics in lipid bilayers probed by a spin label rigidly coupled to the peptide backbone.

Authors:  Christine B Karim; Tara L Kirby; Zhiwen Zhang; Yuri Nesmelov; David D Thomas
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-24       Impact factor: 11.205

9.  Side chain and backbone dynamics of phospholamban in phospholipid bilayers utilizing 2H and 15N solid-state NMR spectroscopy.

Authors:  Shadi Abu-Baker; Jun-Xia Lu; Shidong Chu; Clarke C Brinn; Christopher A Makaroff; Gary A Lorigan
Journal:  Biochemistry       Date:  2007-10-02       Impact factor: 3.162

10.  High-throughput FRET assay yields allosteric SERCA activators.

Authors:  Razvan L Cornea; Simon J Gruber; Elizabeth L Lockamy; Joseph M Muretta; Dongzhu Jin; Jiqiu Chen; Russell Dahl; Tamas Bartfai; Krisztina M Zsebo; Gregory D Gillispie; David D Thomas
Journal:  J Biomol Screen       Date:  2012-08-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.